| CRISX | VSCPX | CRISX / VSCPX | |
| Total Expense Ratio | 1.08 | 0.02 | 5,400% |
| Annual Report Gross Expense Ratio | 1.08 | 0.02 | 5,400% |
| Fund Existence | 29 years | 16 years | - |
| Gain YTD | 19.940 | 14.596 | 137% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 100000000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 73.2M | 189B | 0% |
| Annual Yield % from dividends | 0.69 | 1.24 | 56% |
| Returns for 1 year | 22.76 | 22.59 | 101% |
| Returns for 3 years | 26.19 | 43.45 | 60% |
| Returns for 5 years | 3.90 | 35.15 | 11% |
| Returns for 10 years | 17.47 | 156.12 | 11% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FFNCX | 14.78 | 0.01 | +0.07% |
| Fidelity Advisor Asset Manager 40% C | |||
| EPSYX | 29.55 | -0.05 | -0.17% |
| NYLI Epoch Global Equity Yield Class I | |||
| MSOAX | 38.19 | -0.13 | -0.34% |
| NYLI WMC Enduring Capital Class A | |||
| GAGAX | 38.77 | -0.17 | -0.44% |
| Gabelli Global Rising Income and Div A | |||
| MRSAX | 29.28 | -0.17 | -0.58% |
| MFS Research International A | |||